Synopsis

In a Duke clinical trial exploring a novel cancer therapy, Scott Pelley documents the journeys of patients participating in the groundbreaking research, which has received FDA breakthrough designation. Meanwhile, Bill Whitaker investigates the escalating U.S. campaign against Chinese espionage and the unintended consequences for ordinary Americans caught in the crossfire.